首页> 外文期刊>Dysphagia >Patient Dose During Videofluoroscopy Swallowing Studies in a Hong Kong Public Hospital
【24h】

Patient Dose During Videofluoroscopy Swallowing Studies in a Hong Kong Public Hospital

机译:在香港公立医院进行视频透视检查吞咽研究期间的患者剂量

获取原文
获取原文并翻译 | 示例
           

摘要

A videofluoroscopy swallowing study (VFSS) is a major tool in diagnosing swallowing disorders. Like all other medical examinations that involve irradiation, patient dosage is a major concern. Cerebrovascular accident (CVA) and nasopharyngeal carcinoma (NPC) have been two of the most common indicating pathologies for VFSS studies. The goals of this study were to determine the mean dose area product (DAP) value and fluoroscopic time for VFSS examinations in Tuen Mun Hospital, to compare the result with the dose reference level of other similar studies, and to document the results with respect to the various common indicating pathologies for VFSS (i.e., CVA, NPC). Three hundred ninety-eight VFSS exams were performed at our center in a 24-month period; the mean DAP was 2.42 ± 2.04 Gy cm2 for an effective dose of 0.31 ± 0.26 mSv. The mean fluoroscopic time is 4.23 ± 2.56 min. The P value of 0.0034 was obtained using the Kruskal–Wallis test to compare the DAP from various groups of indicating pathologies. It suggests that there are significant differences in dosage between CVA and NPC patients and the entire population. We conclude that the dose of radiation received by a patient undergoing a VFSS examination in our center was comparable to the international standard and that of other similar studies. We can also conclude that there is a significant difference in dosage between NPC and CVA patients and the overall population suggesting that the indicating pathologies for a VFSS have certain effects on the resulting irradiating dose delivered but more studies have to be done to explain such differences.
机译:视频透视吞咽研究(VFSS)是诊断吞咽障碍的主要工具。像所有其他涉及辐射的医学检查一样,患者剂量也是一个主要问题。脑血管意外(CVA)和鼻咽癌(NPC)已成为VFSS研究中最常见的两种指示病理。这项研究的目的是确定屯门医院VFSS检查的平均剂量面积乘积(DAP)值和荧光检查时间,将结果与其他类似研究的剂量参考水平进行比较,并记录有关VFSS的各种常见指示病理(即CVA,NPC)。在24个月内,我们中心进行了398次VFSS考试;有效剂量为0.31±0.26 mSv时,平均DAP为2.42±2.04 Gy cm 2 。平均透视时间为4.23±2.56分钟。使用Kruskal–Wallis检验比较不同组指示病理的DAP得出的P值为0.0034。这表明CVA和NPC患者与整个人群的剂量存在显着差异。我们得出的结论是,在我们中心接受VFSS检查的患者所接受的辐射剂量与国际标准及其他类似研究相当。我们还可以得出结论,NPC和CVA患者与总体人群之间的剂量存在显着差异,这表明VFSS的指示性病理对所产生的最终辐照剂量有一定影响,但必须做更多的研究来解释这种差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号